Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 12, 2021

View Archived Issues

Ascentage Pharma polycomb protein EED inhibitor displays potency, tumor regression potential

FPR2 agonist NAP-1051 shows promise in preclinical SLE model

SCO-spondin-derived peptide shows neuroprotection and increased synaptic transmission in the CNS

Calreticulin as promising new therapeutic target in breast cancer

PharmaMar describes HER2-targeting antibody-drug conjugates

New MAP4K1 inhibitors discovered at Wigen Biomedicine Technology

Roche patents potassium voltage-gated channel subfamily C member 1 activators

New compounds inhibiting respiratory syncytial virus identified at Janssen

Boehringer Ingelheim presents new HER2 inhibitors

COVA1-18 demonstrates strong antiviral activity against SARS-CoV-2 in vivo

DDR1 promotes immune exclusion in tumors and it is a therapeutic target

Cannabigerol derivatives have anti-inflammatory, analgesic and antiobesity potential

Circulating levels of galectin-1 associated with lower kidney function

Rakovina presents data on in vitro activity of novel dual PARP-HDAC inhibitors

Study shows gut microbiome changes may be effect, not cause, of autism spectrum disorders

Opus Genetics licenses new preclinical program for inherited retinal disease

ITIH4 is a marker for early diagnosis of gastric cancer

Fitness cost of antibiotic-resistant mutants can be used to identify new combination therapies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...